citric acid, anhydrous has been researched along with Hyperlipoproteinemia Type II in 2 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Handschel, D | 1 |
| Etienne Janssens, M | 1 |
| Gericke, M | 1 |
| De Reys, S | 1 |
| Borberg, H | 1 |
| Stefanutti, C | 1 |
| Di Giacomo, S | 1 |
| Di Caro, M | 1 |
| Vivenzio, A | 1 |
| Musca, A | 1 |
2 other studies available for citric acid, anhydrous and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Comparative evaluation of a heparin-citrate anticoagulation for LDL-apheresis in two primary apheresis systems.
Topics: Anticoagulants; Blood Coagulation; Blood Component Removal; Cholesterol; Citric Acid; Female; Hepari | 2017 |
DALI low-density lipoprotein apheresis in homozygous and heterozygous familial hypercholesterolemic patients using low-dose citrate anticoagulation.
Topics: Adolescent; Adsorption; Adult; Anticoagulants; Blood Component Removal; Citric Acid; Female; Heteroz | 2001 |